New target for drug intervention in Alzheimer's disease identified

June 25, 2019

BIRMINGHAM, Ala. - Scientists at the University of Alabama at Birmingham have identified an enzyme in the brain that may be an intriguing target for interventions against Alzheimer's disease and other dementias.

The researchers suggest that the enzyme, a serine/threonine kinase known as LIMK1, may play an important role in the degradation of dendritic spines, the connections between neurons in the brain. In a paper published June 25 in Science Signaling, the team reports on the use of an experimental medication that appears to successfully inhibit LIMK1 and provide a level of protection for dendritic spines.

"This is the first study to showcase that inhibiting LIMK1 could provide a protective effect for dendritic spines," said Jeremy Herskowitz, Ph.D., assistant professor in the Department of Neurology, School of Medicine at UAB. "In animal models, we've shown that increased activity of LIMK1 is linked to changes in the length and density of dendritic spines, which has implications for Alzheimer's."

Think of dendritic spines as bridges connecting one neuron to another. Previous research in Herskowitz's laboratory showed that individuals with longer and more numerous spines did not develop symptoms of dementia, even if they had the well-known Alzheimer's pathology of amyloid plaques and tau tangles.

"In a healthy brain, LIMK1 appears to regulate the size and density of dendritic spines," Herskowitz said. "In dementia, the enzyme is overactive, leading to damage to the spines. In this study, we were able to provide a protective effect to the dendritic spines by means of an experimental drug that inhibited activity of LIMK1."

LIMK1 resides downstream of two other enzymes known to be associated with dementia. These Rho-associated kinases, known as ROCK 1 and ROCK 2, are increased in early Alzheimer's disease, Herskowitz says. Investigators worldwide have looked to ROCK 1 and 2 as potential intervention targets in dementia.

"The ROCK kinases are proving to be challenging drug targets because inhibiting them may cause severe side effects -- including a drop in blood pressure significant enough to cause death," Herskowitz said. "But LIMK1, downstream in the signaling pathway, is regulated by the ROCK kinases, particularly ROCK 2. As far as we know now, inhibition of LIMK1 has no effect on ROCK, and so it may not carry the same severe side effects."

LIMK1 is also thought to play a role in cancer metastasis, so Herskowitz's team turned to an experimental drug called SR7826, which is under development as a cancer therapeutic. SR7826 suppresses the activity of LIMK1. In an animal model, a single dose given once daily for 10 days boosted dendritic spine density and increased the length of the spines.

"The drug had remarkable effects on the dendritic spines, results that we feel are significant and promising," Herskowitz said. "We observed no negative side effects."

Herskowitz says further studies will be needed to see if the effect continues over time and if any negative effects develop.

"This is one of the first scientific papers to suggest that LIMK1 might be a better target for intervention than the Rock kinases," he said. "Another important aspect of this sort of target is that it could lead to an intervention before loss of cognitive function has begun. It could provide a protective effect to prevent damage or loss of dendritic spines."
-end-
The study was funded by the National Institute on Aging, one of the National Institutes of Health.

University of Alabama at Birmingham

Related Brain Articles from Brightsurf:

Glioblastoma nanomedicine crosses into brain in mice, eradicates recurring brain cancer
A new synthetic protein nanoparticle capable of slipping past the nearly impermeable blood-brain barrier in mice could deliver cancer-killing drugs directly to malignant brain tumors, new research from the University of Michigan shows.

Children with asymptomatic brain bleeds as newborns show normal brain development at age 2
A study by UNC researchers finds that neurodevelopmental scores and gray matter volumes at age two years did not differ between children who had MRI-confirmed asymptomatic subdural hemorrhages when they were neonates, compared to children with no history of subdural hemorrhage.

New model of human brain 'conversations' could inform research on brain disease, cognition
A team of Indiana University neuroscientists has built a new model of human brain networks that sheds light on how the brain functions.

Human brain size gene triggers bigger brain in monkeys
Dresden and Japanese researchers show that a human-specific gene causes a larger neocortex in the common marmoset, a non-human primate.

Unique insight into development of the human brain: Model of the early embryonic brain
Stem cell researchers from the University of Copenhagen have designed a model of an early embryonic brain.

An optical brain-to-brain interface supports information exchange for locomotion control
Chinese researchers established an optical BtBI that supports rapid information transmission for precise locomotion control, thus providing a proof-of-principle demonstration of fast BtBI for real-time behavioral control.

Transplanting human nerve cells into a mouse brain reveals how they wire into brain circuits
A team of researchers led by Pierre Vanderhaeghen and Vincent Bonin (VIB-KU Leuven, Université libre de Bruxelles and NERF) showed how human nerve cells can develop at their own pace, and form highly precise connections with the surrounding mouse brain cells.

Brain scans reveal how the human brain compensates when one hemisphere is removed
Researchers studying six adults who had one of their brain hemispheres removed during childhood to reduce epileptic seizures found that the remaining half of the brain formed unusually strong connections between different functional brain networks, which potentially help the body to function as if the brain were intact.

Alcohol byproduct contributes to brain chemistry changes in specific brain regions
Study of mouse models provides clear implications for new targets to treat alcohol use disorder and fetal alcohol syndrome.

Scientists predict the areas of the brain to stimulate transitions between different brain states
Using a computer model of the brain, Gustavo Deco, director of the Center for Brain and Cognition, and Josephine Cruzat, a member of his team, together with a group of international collaborators, have developed an innovative method published in Proceedings of the National Academy of Sciences on Sept.

Read More: Brain News and Brain Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.